Related Experiment Video
Updated: Mar 6, 2026
09:37
Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
15.6K
Anaesthesia in patients with liver disease
Malgorzata H Starczewska1, Wint Mon, Peter Shirley
1aAdult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust bUniversity College London Hospitals NHS Foundation Trust, London, United Kingdom.
Current Opinion in Anaesthesiology
|March 18, 2017
Summary
Anesthetic management for patients with liver disease requires careful preoperative assessment and planning. Optimizing perioperative care for patients with chronic liver disease (CLD) is crucial to reduce high surgical risks.
Area of Science:
- Anesthesiology
- Hepatology
- Surgical Patient Management
Background:
- Chronic liver disease (CLD) incidence is rising, leading to high perioperative mortality and morbidity.
- Patients with cirrhosis face significantly increased risks during elective surgery.
- Effective anesthetic management is vital for improving surgical outcomes in liver disease patients.
Purpose of the Study:
- To review current research and recommendations for anesthetic management in surgical patients with liver disease.
- To highlight the importance of preoperative assessment and planning for this patient group.
- To provide up-to-date information for clinicians managing liver disease patients undergoing surgery.
Main Methods:
- Review of recent research data and clinical recommendations.
- Analysis of established and emerging risk assessment scoring systems.
- Evaluation of anesthetic agents and perioperative management strategies.
Main Results:
- Cirrhosis substantially increases postoperative morbidity and mortality risks.
- Child-Pugh-Turcotte and MELD scores are key for risk assessment; newer indices may offer improved prognostic value.
- Recommended anesthetic agents include propofol and sevoflurane/desflurane, with careful opiate titration due to altered metabolism. Close hemodynamic monitoring and critical care admission are advised.
Conclusions:
- Anesthesia for patients with liver disease presents significant challenges.
- Advanced planning and preparation are essential for improving perioperative outcomes.
- Meticulous anesthetic management is critical for reducing risks in this population.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
01:24General Anesthesia: Overview
906
Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
906
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
304
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
304
01:28Esophageal Varices-II: Clinical Features and Management
697
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
697
01:24Parenteral Anesthetics: Overview
844
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
844
01:11Local Anesthetics: Clinical Application as Spinal Anesthesia
1.7K
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.7K